What causes recurrence of bacterial vaginosis in women of reproductive age?

What Causes Recurrence of Bacterial Vaginosis?

Recurrence of bacterial vaginosis is primarily caused by sexual reinfection from untreated male partners, persistence of biofilm-protected bacteria after antibiotic treatment, and failure of protective Lactobacillus species to recolonize the vagina.

Sexual Transmission and Partner Reinfection

The most significant breakthrough in understanding BV recurrence comes from recent evidence demonstrating that treating male partners reduces recurrence rates from 63% to 35% within 12 weeks 1. This landmark 2025 trial definitively established that:

• Sexual reinfection from untreated male partners is a major driver of recurrence, with bacterial vaginosis-associated organisms being exchanged between partners during sexual activity 2, 1
• The absolute risk reduction of 2.6 recurrences per person-year when treating both partners confirms that BV has a sexually transmitted component 1
• Multiple sexual partners in the previous year significantly increases recurrence risk 3

This contradicts older CDC guidelines from 1993-2002 that stated partner treatment was ineffective 4, but those recommendations have been superseded by newer molecular and epidemiological evidence 5, 2.

Biofilm Persistence and Antimicrobial Resistance

Biofilm formation by BV-associated bacteria protects them from antimicrobial therapy, allowing residual infection to persist after treatment 6, 7:

• BV-associated bacteria form protective biofilms in the vaginal canal that antibiotics cannot fully penetrate 8, 6
• Both vaginal epithelial cells and bacterial cells possess enzymes that metabolize antibiotics and transporter proteins that expel drugs, rendering them ineffective 8
• This pharmacomicrobiomics phenomenon—drug-microbiome interactions in the vaginal environment—reduces antibiotic efficacy and increases recurrence risk 8

Failure of Lactobacillus Recolonization

After antibiotic treatment, beneficial Lactobacillus species (particularly L. crispatus) often fail to recolonize the vagina, leaving it vulnerable to dysbiosis 7, 9:

• Antibiotics provide short-term cure but do not restore a healthy, Lactobacillus-dominant microbiome 7
• Without protective Lactobacillus species producing hydrogen peroxide and lactic acid, the vaginal environment remains susceptible to overgrowth by anaerobic bacteria 4
• This explains why 50-80% of women experience recurrence within one year despite initial antibiotic cure 6, 7

Additional Contributing Factors

Several behavioral and clinical factors increase recurrence risk 3, 7:

• History of other vaginal infections (HPV, other vaginitis) increases recurrence likelihood 3
• Lower educational level correlates with higher recurrence rates 3
• Smoking increases risk, while smoking cessation may be protective 3, 7
• Lack of condom use facilitates bacterial exchange with partners 7
• Age at first sexual intercourse and sexual hygiene practices affect risk 3

Clinical Implications

The high recurrence rate (30-70% within 3-6 months) 8, 9 reflects the multifaceted nature of BV pathogenesis:

• Standard antibiotic therapy alone addresses only the immediate bacterial overgrowth, not the underlying causes of recurrence 6, 7
• Recurrence is not unusual, and patients should be counseled to return if symptoms reappear 4, 5
• The CDC notes that more than 63% of women completing maintenance therapy continue to have ongoing infections 4

Common Pitfalls

Do not assume recurrence represents treatment failure or antibiotic resistance alone—it more likely reflects reinfection from partners, biofilm persistence, or microbiome failure to restore 2, 9. The outdated practice of treating women only while ignoring male partners has been definitively shown to be inferior 1.